Summary Tumor necrosis element-similar apoptosis-inducing ligand (TRAIL) is actually a cytotoxic cytokine that induces cancer cell Dying by binding to TRAIL receptors. Thanks to its selective cytotoxicity toward most cancers cells, TRAIL therapeutics, which include recombinant TRAIL and agonistic antibodies targeting Path receptors, have garnered notice as promising cancer treatment https://maynardo520fkn3.blogsidea.com/profile